Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer

被引:3
|
作者
Koenigsrainer, Ingmar [1 ]
机构
[1] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, D-72076 Tubingen, Germany
关键词
Peritoneal carcinomatosis; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery; Selection criteria; PHOSPHOGLYCERATE KINASE 1; PERITONEAL CARCINOMATOSIS; DISSEMINATION; THERAPY;
D O I
10.3748/wjg.v17.i37.4153
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Peritoneal carcinomatosis in gastric cancer is associated with a dismal prognosis. Systemic chemotherapy is not effective because of the existence of a blood-peritoneal barrier. Cytoreductive surgery and intraperitoneal chemotherapy can improve survival and quality of life in selected patients. Patient selection for this multimodal approach is one of the most critical issues, and calls for interdisciplinary evaluation by radiologists, medical and surgical oncologists, and anaesthetists. This article sets forth criteria for selection of gastric cancer patients suffering from peritoneal carcinomatosis. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:4153 / 4156
页数:4
相关论文
共 50 条
  • [21] Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Brandl, Andreas
    van Sandick, Johanna W.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (07)
  • [22] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Advanced Gastric Cancer: A Western Perspective
    Rosa, Fausto
    Alfieri, Sergio
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E205 - E206
  • [23] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre
    Hayler, Raymond
    Domingos, Natalie
    Ashrafizadeh, Amir
    Wijayawardana, Ruwanthi
    Ahmadi, Nima
    Liauw, Winston
    Morris, David
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [24] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection
    Esquivel, Jesus
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (01) : 72 - 78
  • [25] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer
    Polom, Karol
    Roviello, Giandomenico
    Generali, Daniele
    Marano, Luigi
    Petrioli, Roberto
    Marsili, Stefania
    Caputo, Edda
    Marrelli, Daniele
    Roviello, Franco
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (03) : 298 - 310
  • [26] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer
    Glockzin, Gabriel
    Schlitt, Hans J.
    Piso, Pompiliu
    CHIRURGISCHE GASTROENTEROLOGIE, 2007, 23 (04): : 347 - 352
  • [27] Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Rebecca M. Dodson
    Michael Kuncewitch
    Konstantinos I. Votanopoulos
    Perry Shen
    Edward A. Levine
    Annals of Surgical Oncology, 2018, 25 : 2152 - 2158
  • [28] Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Dodson, Rebecca M.
    Kuncewitch, Michael
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (08) : 2152 - 2158
  • [29] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
    Kim, Dong-Wook
    Park, Dong-Guk
    Song, Sanghyun
    Jee, Ye Seob
    JOURNAL OF GASTRIC CANCER, 2018, 18 (03) : 296 - 304
  • [30] Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
    Rihuete Caro, Cristina
    Manzanedo, Israel
    Pereira, Fernando
    Carrion-Alvarez, Lucia
    Serrano, Angel
    Perez-Viejo, Estibalitz
    EJSO, 2018, 44 (11): : 1805 - 1810